idexx deliv strong first quarter expect substanti
impact second quarter
updat forecast estim may
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim may
price data may
rate updat may
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
steadili increas scale reach
veterinari diagnost lab busi dig narrow moat
well-posit benefit two key trend first pet ownership
continu grow household own pet
compar moreov pet owner
demonstr greater willing spend anim
tripl spend pet product servic
offer impress wide rang companion anim
diagnost test deliv mani form exampl carv
leadership posit single-us test kit in-offic use
conveni result less minut mani routin
recur diagnost switch outsid lab kit idexx
also maintain strong posit off-sit lab test anoth area
histor seen double-digit growth final enjoy
leadership posit in-hospit analyz focu
develop broaden menu test make
one-stop shop anim hospit uniqu abl
cross-sel mani product servic develop
strong sale organ provid tailor solut
abil sniff opportun build better mousetrap
cross smaller water-test production-animal-test
busi municip often requir routin test
water suppli offer uniqu test detect two
common bacteri contamin easier faster
use tradit test method allow firm
captur water market also
leader livestock poultri diagnost includ test
foot-and-mouth diseas although segment seen
growth consist pet busi gener
offer fatter margin anticip mani year growth ahead
rise incom emerg market feed appetit anim
protein like innov demonstr
expect come
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
idexx laboratori primarili develop manufactur distribut
diagnost product equip servic pet livestock key
product line includ single-us canin felin test kit veterinarian
employ offic benchtop chemistri hematolog analyz
test-panel analysi on-sit refer lab servic test detect
manag diseas livestock get revenu
outsid unit state
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
idexx deliv strong first quarter expect
substanti impact second quarter apr
post robust first-quart result
much line accustom see
firm despit shelter-in-plac order
damp vet offic traffic second half march
hold steadi fair valu estim still expect
pressur margin show next
quarter along slower top-lin growth consid
there like dip high-margin consum along
idexx goal keep refer lab open
rel high fix cost weigh profit
near term nonetheless see noth suggest
idexx strong narrow moat erod think firm
cost advantag network refer lab
well switch cost associ benchtop analyz
weather crisi fine
actual suspect firm intang asset may grow
stronger pandem ensu recess
particular long deliv high-touch
servic support veterinarian realli shine
moment vet reli even heavili relationship
field forc rejigg workflow
accommod social-distanc order keep anim
hospit personnel custom safe expect vet
also lean help ramp adapt
oper state begin loosen guidelin normal
activ support view idexx posit moat
despit concern recessionari condit
weigh idexx companion anim busi
hearten see increas adopt
foster shelter pet pandem
anticip new pet owner need seek pet
healthcar line bode well
modestli lower fair valu estim
per share incorpor
crisi weigh result follow
recessionari condit estim
revenu growth prior
project expect mid-single-digit top-lin
growth return
remain bullish vetlab consum
refer lab segment -- two largest fastest-grow
product line companion anim segment -- despit
near-term pressur pandem still
expect aggress placement instrument
steadi stream new test assay pay
longer term consum return normal
low doubl digit consid
opportun cross-sel on-going progress
penetr new anim hospit analyz
instrument believ plenti potenti
sale consult sell new servic develop stickier
relationship immedi crisi
normal cours busi consist roll
new product recept companion anim practic
though process may slow near term
anticip robust companion anim growth primarili
fed adopt seri new product larger
base analyz sale ancillari servic grow
strength consum refer lab consid
adopt curv in-hous diagnost equip
tend slow steadi sever year
benefit string new product launch
deck next five year
nonetheless share still look overpr us continu
think takeout premium inflat stock
find difficult justifi share price
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
mild expect growth
companion-anim segment recov histor
double-digit level market
roughli basi point annual -- manufactur
effici attain hike fair valu estim
per share
hand crisi may sever
econom recoveri may slower expect
case assum low-single-digit top-lin growth
increment progress reach
remaind explicit forecast period match
long-term growth pet healthcar market firm
also slip cost control key rapid assay kit
succumb competit reduc fair valu estim
per share
leader point-of-car diagnost test
in-hous analyz equip hold well-establish
posit refer lab duopoli vca part
privat held mar econom moat driven
sever sourc first firm reli intellectu properti
protect know-how goe diagnost test
abil
consist innov diagnost test firm come
new gener assay laboratori
equip test diseas appli
emerg diagnost technolog previous invent
human product anim water test well
companion anim product servic
typic focu test new type diseas
parasit improv turnaround time test result
increas accuraci result enhanc
conveni on-sit test firm also offer
integr vet practic manag softwar packag
simplifi transmiss test data patient medic
even though recent trade downward revers
engin current share price wed need assum
deliv compound annual top-lin growth
consist idexx three-year
histor revenu compound-annual-growth-rate assum
impact top line addit firm would need
deliv basi point improv oper
margin next five year exceed base-cas
assumpt basi point
base larg averag volatil cash flow
divers product portfolio rate uncertainti
base case assum
substanti effect near-term perform
follow two year gradual recoveri longer
term expect abl expand busi
ahead market time frame
adopt
instrument associ
consum strong refer lab perform drive
top-lin growth upsid impact
new
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
second moat bolster switch cost across
number product exampl
cornerston practic manag softwar
anim hospit staff invest time enter
patient client inform becom familiar
softwar inconveni instal learn
whole new system mean custom tend stick
principl appli in-hous test
equip practic instal base
equip train vet tech practic
like stick switch anoth brand
custom switch cost also rise vet practic
purchas multipl product servic
exampl custom retent notic higher
practic combin refer lab in-hous
analyz softwar integr
final also enjoy cost advantag
diagnost lab extens scale larg
nation lab network abl run test lower
cost thank higher throughput volum ensu
effici use lab result attract margin
smaller-scal independ lab offer
rival vca antech creat duopoli market
built rout network dens
effici element contribut
moat render price tertiari factor
gain scale allow make serial
acquisit new competitor might emerg
seriou threat recent solidifi
posit europ new major refer lab
germani enter biomed clinic test market
acquisit radil acquir distributor
brazil
sanofi bayer
see moat trend posit sever reason
production-anim diagnost market popul
group smaller pure-play compani pharmaceut
commercial-anim diagnost tini contributor
larger busi think unlik larg pharma
competitor focu much attent market
often seek much bigger profit fish fri even
anim health pharma pure-play zoeti tend focu
therapeut product companion product
anim smaller portfolio diagnost product
hand small pure play like advanc
anim diagnost could appeal purchas
companion-anim refer lab segment
vca primarili split domest market special
type lab test continu conduct anim
hospit lab associ veterinari school
major bread-and-butt test handl within
duopoli
anim diagnost impress record
introduc innov thank robust spend
account estim spend
anim diagnost market made
attract partner pharmaceut firm would like
market therapi along companion
diagnost exampl boehring ingelheim team
market vetmedin treat congest heart failur
dog along cardiopet probnp test
provid earli detect heart failur anim medicin
continu move path pair therapi
diagnost expect highli sought
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equip though diagnost test sent
refer lab result within follow two
day turnaround in-hous equip faster
conveni vet practic trade anim
hospit higher-margin in-hous test reap
financi reward even diagnost test
divert refer lab note
make steadi progress persuad practic use
competit in-hous analyz switch idexx
equip grow base instal unit bode well
continu stream consum revenu
final think bold decis institut all-direct
distribut instrument consum rapid assay
kit histor sold tradit
vet distributor includ henri schein patterson
mwi paid long run although firm requir
increment invest build infrastructur
staff necessari support sale model expect
hold margin profit product
minim risk lose market share competitor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ounlik human healthcar pet health servic
reimburs issu price pressur
associ third-parti payer
oanecdot inform vet suggest
well-integr user-friendli practic manag
softwar help hospit switch stick
product servic
oidexx sale custom support staff garner high
mark provid high-touch servic vet practic
ointern sale account substanti chunk
total revenu dollar strengthen
would feel pain top bottom line
oidexx rapid assay product line vulner
competit pressur vet distributor
firm could see growth area stagnat declin
owhil cardiopet probnp seen impress uptak
thu far key veterinari cardiologist held
enthusiast endors vari
interpret test result across dog breed
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi health strong firm histor
fund expans acquisit primarili
cash gener held virtual long-term debt
unlik rival vca mani year ago ran
financi problem increas leverag fund
substanti expans taken financi
conserv approach consid firm throw
free cash flow percentag sale low-
mid-teen manag deploy strateg
acquisit share buyback firm decid
leverag balanc sheet increas debt roughli
time debt/ebitda manag target debt
remain rang intent use
cash fund share repurchas think level debt
manag especi consid
steadi cash flow hinder firm
flexibl choos pursu larger acquisit
opportun howev firm fallen
target rang recent sinc expect
firm end debt/ebitda around time
base larg averag volatil cash flow
divers product portfolio rate uncertainti
medium medic diagnost technolog
remain vulner potenti technolog
consum spend
spend -- show less vet traffic reluct
spend diagnost well vet hold
purchas new upgrad equip
pressur livestock poultri product industri
may translat heighten competit less
negoti leverag time regulatori agenc
chang guidelin livestock poultri test
protein market suffer excess suppli
prolong low price rippl effect part
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
busi zoeti recent acquisit abaxi could
translat stiffer competit instrument
consum
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
fidel manag research compani
share
fund
share
fund
think stewardship exemplari
outgo ceo chairman jonathan ayer step
role lead carrier unit unit
technolog seven year ayer step
follow seriou cycl accid remain
confid new ceo jay mazelski current cfo brian
handili execut
strategi serv well
fan level detail disclosur compani
provid well preponder outsid
board past former ceo ayer
held posit chairman complement
execut posit remain board
lawrenc kingsley appoint chairman kingsley
bring impress diagnost experi time
pall
like ceo requir report success
plan board least annual think
definit paid transit ceo gone
plan emphas restrict stock vest five year
point mazelski ownership share decent
though expect increas take ceo
respons think share ownership
director remain light would like see boost
stake put skin game
balanc think manag made wise
capital-alloc decis think rack
admir record acquisit made
number purchas make strateg sens
reason price includ bomm diagnost expand
footprint product anim diagnost across europ
dvminsight bolster telemedicin capabl
radil gain foothold biomed research market
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
import
staf train
perhap
manag will pass deal
opportun enhanc valu asid
merger acquisit like manag
intern
consist upgrad instrument roll new assay
panel importantli partner vet main
critic stewardship focus share
repurchas mainli stock typic bought
premium valuat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
form narrow-moat finish
double-digit constant-curr top- bottom-
line growth fourth quarter consid nearli
hit estim nose project
within bound manag outlook
hold steadi fair valu estim idexx
share remain overvalu perspect like
reflect takeout premium boost merger
acquisit petcar industri past year
investor accustom even stronger
midteen growth companion anim diagnost might
disappoint fourth-quart result
think well-posit sustain low-double-digit
growth unit thank firm prowess innov
idexx moat trend posit line new product
meaning improv exampl think
impend launch idexx new digit cytolog
appeal vet help support robust refer lab
growth cytologytest tissu fluid
pathologiescan extrem help diagnos
condit includ mang tumor cancer
anticip cytolog test bone marrow popular
consid preval cancer dog
common blood test may detect cancer flag
specimen slide cytolog send
interpret veterinari pathologist could take day
turn around idexx new servic support global
presenc bench strength clinic pathologist
deliv expert interpret two hour everi day
consider leap forward skeptic mani
competitor could replic kind servic
global infrastructur employe base requir
idexx main competitor refer lab market vca
own mar footprint mainli north
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
